ANNOUNCEMENT 20 Jun 2019

In June 2019, the European Investment Bank (EIB) signed a loan agreement with Mauna Kea Technologies SA to support its product development related to certain medical microscopes. 

NUMBER OF INTERVENTIONS

1

  • 1 harmful
  • 0 neutral
  • 0 liberalising

SOURCE

The European Investment Bank, Project Summary, MAUNA KEA TECHNOLOGIES (EGFF): https://www.eib.org/en/projects/pipelines/all/20180349
Mauna Kea Technologies SA: https://www.maunakeatech.com/en/about-us/17-our-story

Inception date: 20 Jun 2019 | Removal date: open ended

State loan

On 20 June 2019, the European Investment Bank (EIB) and Mauna Kea Technologies SA signed a loan agreement having a total value of EUR 22 million (approx. USD 25 million). The loan will support the company's product development related to medical microscopes. More specifically, the company aims at developing new "in-vivo endo-microscope" to be used in connection with biopsies and other surgical procedures. 

Mauna Kea Technologies SA is headquartered in France and is a developer and producer medical microscopes. The company's products are sold in more than 40 countries worldwide.

A state act in the GTA database is assessed solely in terms of the extent to which its implementation affects foreign commercial interests. On this metric, the investment support granted here is discriminatory.

AFFECTED SECTORS

 

AFFECTED PRODUCTS